| 000 | 01477nam a2200241 4500 | ||
|---|---|---|---|
| 001 | 392655 | ||
| 010 | _a9789291687398 | ||
| 090 | _a392655 | ||
| 100 | _a20140715d2014 y0pory50 ba | ||
| 101 | _aeng | ||
| 200 |
_aGeneral report of activities 2013 _ekey achievements and governance _ea year in review |
||
| 210 |
_aLuxembourg _cPublications Office of the European Union _d2014 |
||
| 215 |
_a104 p. _d30 cm |
||
| 330 | _aForeword. Introduction. Part I - Report of activities: Key achievements and governance. Chapter 1 - Executive summary; Chapter 2 - Core business: monitoring and reporting on the drugs problem in Europe; Chapter 3 - Cooperation and collaboration with key partners; Chapter 4 - Supporting the achievement of results; Part II - Chapter 5 - Characteristics and nature of EMCDDA management and internal control systems; Chapter 6 - Assessment and improvement of management and internal control systems; Chapter 7 - Declaration of assurance by Authorising Officer and Management Board's analysis and assessment of the Authorising Officer's General Report of Activities for the financial year 2013. Annexes. | ||
| 606 |
_aRELATÓRIO ANUAL _9299235 |
||
| 606 |
_aCOMBATE À DROGA _9410441 |
||
| 606 |
_aEMCDDA _9324041 |
||
| 710 |
_aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION _9351987 |
||
| 955 | _xOferta | ||